| Adeyeye MC, Jain AC, Ghorab M, Reilly WJ.
Viscoelastic Evaluation of Topical Creams Containing Microcrystalline Cellulose/Sodium Carboxymethyl Cellulose as Stabilizer.
AAPS PharmSciTech. 2002; 3(2): article 8.
| Moji Christianah Adeyeye,1
Ashwinkumar C. Jain,1
Mohamed K.M. Ghorab,1
and William J. Reilly, Jr2
1Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282 2Independent Pharmaceutical Formulation Consultant, New Hope, PA 18938
Correspondence to: Moji Christianah Adeyeye Tel: (412) 396-5133 Fax: (412) 396-5599 Email: adeyeyechri@duq.edu | Submitted: November 14, 2001; Accepted: December 7, 2001; Published: May 30, 2002 | Keywords:
Viscoelastic, Microstructure, Cream, Avicel CL-611, Hydrocortisone acetate, Storage modulus | The purpose of this study was to examine the viscoelastic properties of
topical creams containing various concentrations of microcrystalline
cellulose and sodium carboxymethyl cellulose (Avicel® CL-611) as a
stabilizer. Avicel CL-611 was used at 4 different levels (1%, 2%, 4%, and
6% dispersion) to prepare topical creams, and hydrocortisone acetate was
used as a model drug. The viscoelastic properties such as loss modulus (G’’), storage modulus (G’), and loss tangent (tan δ) of these creams were measured using
a TA Instruments AR 1000 Rheometer and compared to a commercially available
formulation. Continuous flow test to determine the yield stress and thixotropic
behavior, and dynamic mechanical tests for determining the linear viscosity time
sweep data, were performed. Drug release from the various formulations was studied
using an Enhancer TM Cell assembly. Formulations containing 1% and 2% Avicel
CL-611 had relative viscosity, yield stress, and thixotropic values that were
similar to those of the commercial formulation. The elastic modulus (G’) of the 1% and 2% formulation was relatively high and did not cross the
loss modulus (G’’), indicating that the gels were strong. In the commercial formulation, G’ increased after preshearing and broke down after 600 seconds. The strain
sweep tests showed that for all formulations containing Avicel CL-611, the G’ was above G’’ with a good distance between them. The gel strength and the predominance of G’ can be ranked 6% > 4% > 2%. The strain profiles for the 1% and 2%
formulations were similar to those of the commercial formulation. The δ values
for the 1% and 2% formulations were similar, and the formulations containing 4% Avicel
CL-611 had lower δ values, indicating greater elasticity. Drug release from
the commercial preparation was fastest compared to the formulations prepared using Avicel
CL-611, a correlation with the viscoelastic properties. It was found that viscoelastic
data, especially the strain sweep profiles of products containing Avicel CL-611 1% and
2%, correlated with the commercial formulation. Rheological tests that measure the
viscosity, yield stress, thixotropic behavior, other oscillatory parameters such as G’ and G’’ are necessary tools in predicting performance of semisolids.  |
Products such as topical creams are designed for protracted residence on
the skin and undergo a wide variety of stresses during removal from the
container and application to the affected area. Therefore, it is important to
consider the effects of such stress on the microstructure of products.
Microstructural characteristics (e.g, lamellar gel phase, interfacial layer
or membrane of the dispersed phase, micellar formation and physical stability,
flocculation, ratio of free and bound water to surfactants) of topical
creams-pharmaceutical, cosmetic, or food-have been evaluated using several
analytical methods. These methods include viscoelastic measurements1-4 low- and high-angle X-ray diffractometry2, confocal laser scanning microscopy5 thermogravimetry6, low-temperature scanning electron microscopy1,7,8, differential scanning calorimetry9, and 17O nuclear magnetic relaxation10. More microstructure investigations have focused on foods than on
pharmaceuticals. Therefore, microstructural characterization of topical
pharmaceutical creams using methods such as rheology is necessary. Rheological
or viscoelastic measurements are generally done to quantify the effects of
aging, temperature, ingredients, and processing parameters on formulations.
Additionally, they are performed to describe quantitatively the flow of a
material for the purpose of quality control (eg, pumping through pipes or
tubes during processing; ease of dispensing of product from tubes, bottles,
or jars; and spreadability on the skin surface)11. Additionally, textural analysis can be used for selection of candidate
formulations for clinical applications12,13. Viscoelastic properties are derived from testing of materials without
destroying the structure (i.e., the structure is flexed and material is measured
in its "ground state"). The measurements are done through rheological flow and
dynamic mechanical tests. The former investigates the flow viscosity, whereas
the latter evaluates small periodic deformations that determine breakdown or
rearrangement of structure or hysteresis. The dynamic mechanical "strain sweep" test examines the microstructural
properties of the material under increased strain. It measures the storage
modulus, G’, which is an indicator of elastic behavior and
reveals the ability of the polymer system to store elastic energy associated
with recoverable elastic deformation. The loss modulus, G’’, is a measure of the dynamic viscous behavior that relates to the
dissipation of energy associated with unrecoverable viscous loss. The loss
tangent (tan δ) is defined as the ratio of the loss modulus to the
storage modulus and is dimensionless. It is a measure of the ratio of energy
lost to energy stored in a cycle of deformation and provides a comparative
parameter that combines both the elastic and the viscous contribution to the
system11,14. The relationship between G’, G’’, and tan δ is shown in equations 1 and 2:
G* is the complex modulus, a measure of the material’s
overall resistance to deformation, and i is the imaginary number, i = √ -1 12. Tan δ values were found to be of great interest in
modeling viscoelastic behavior and were successfully used by Gasperlin et
al 15 to study lipophilic semisolid systems. The dynamic viscosity η’ is a function of the
complex viscosity η’’ and is related to the
steady shear viscosity. It measures the rate of energy dissipation in a
viscoelastic material. The relationship between η’ and
loss modulus (G’’) is given in equation 3:
Various cellulose derivatives such as hydroxypropyl methylcellulose,
hydroxyethyl cellulose, and sodium carboxymethylcellulose (NaCMC) have been
used in the development of topical pharmaceutical cream emulsions. However,
newer excipients such as Avicel CL-611 have not been well characterized as a
dispersion stabilizer in topical preparations. Avicel CL-611 is
microcrystalline cellulose coprocessed with a portion of NaCMC (11.3%-18.8%)
that provides thixotropic behavior to the corresponding semisolid structural
network formed 16,17. The hydrocolloids, the group to which colloidal Avicel CL-611
belongs, generally favor oil/water emulsions. They form very good hydrophilic
barriers via adsorption on drug particles to form a 3-dimensional network
structure within the system, thus sterically stabilizing the system. The
consequence is increased viscosity (due to particle-particle interaction) or
stabilization of the system without a corresponding increase in the oil
phase of emulsions. The aim of the present work was to investigate the rheological
properties of creams (oil/water emulsions) prepared using various levels
of Avicel CL-611 as the phase stabilizer and to study the drug release
of the various formulations in comparison to a marketed formulation.
 | | Materials Avicel CL-611 was supplied by FMC Corporation, Princeton, NJ.
Hydrocortisone acetate was purchased from Sigma Chemical Co., St. Louis,
MI. Propylene glycol, methylparaben, propylparaben, cetyl alcohol, and
glyceryl monostearate were all purchased from Spectrum Quality Products,
New Brunswick, NJ. All solvents used in High Pressure Liquid
Chromatography [HPLC] analysis were HPLC grade unless otherwise noted
and were used as received. The commercial (oil/water) cream used in this
study was Lanocort 10 containing 1% hydrocortisone acetate. Other
ingredients in the formulation included aloe, ceteareth-20, cetearyl
alcohol, cetyl alcohol, methylparaben, propylparaben, sorbitol, water,
and zinc pyrithione. MethodsPreparations of creams The oil phase ingredients and the aqueous phase ingredients
(containing the Avicel CL-611 dispersion) were mixed separately and
heated to 70°C. The aqueous phase and the oil phase ingredients are
listed in Table 1. The oil phase was then added to the aqueous phase and mixed with a Lightnin® mixer
(Aldrich Chemical Co., Milwaukee, WI) at 500 rpm for 2 minutes followed by increasing the
speed to 1000 rpm for 10 minutes. The hot creams were poured into ointment tubes and allowed
to cool for solidification. Different levels of Avicel CL-611 (1%, 2%, 4%, and 6% w/w) were
used to develop oil/water creams. Based on a preliminary study, 4 replicate batches of creams
containing 1% and 2% Avicel CL-611 only were made. Each formulation contained 1% hydrocortisone
acetate as model drug.
Rheological studies Rheological testing of the various cream formulations was performed
at ambient temperature using a control-stress rheometer (TA Instrument
AR 1000N). The general conditions for all tests included the use of a
4-cm acrylic plate with solvent trap and 1600-µ gap. Steady shear A flow test was used to determine the relative viscosity of all
formulations with the following parameters: For the upcurve, a
continuous ramp with shear rate as controlled variable (0-100 1/sec),
log mode, 2 minutes ramp duration at 25°C was applied. The same
procedure was used for the downcurve with reversed shear rate
(100-0 1/sec) to measure thixotropy and yield stress. Dynamic Mechanical TestingStrain sweep All test samples were subjected to constant frequency
(10 rad/sec) using an amplitude ramp with 0.2%-100% strain at 25°C.
The aim was to investigate the structural properties of the creams
under increased strain. Time sweep Each sample was subjected to preshearing (1 minute applied value of
20 1/sec shear rate at 25°C). The aim was to examine the structure
recovery after the structure was broken down. The samples were subjected
to a frequency of 10 rad/sec, with a 1.0% strain (this value was part
of the established procedure in the laboratory used) as controlled
variable for 30 minutes at 25°C. Drug Release StudyThe drug release from various formulations was evaluated using
United States Pharmacopoeial [USP] Type II apparatus and an Enhancer®
Cell assembly18. The release medium consisted of 200 mL of 60% vol/vol ethanol.
A polyethylene membrane (CoTran, 3M Pharmaceuticals, St. Paul, MN) was
used as the permeating membrane. A 1-mL sample was withdrawn at 1, 2,
3, 4, 6, and 8 hours. The analysis sample (50 µL) was directly injected
into the HPLC for analysis. Drug release from a commercial formulation
was compared to that of the creams prepared in the laboratory. HPLC AssayThe concentration of hydrocortisone acetate released was quantified
by a reverse-phase HPLC method. A C18 column (4.6 x 100 mm, 5 µm)
(Phenomenex, Torrance, CA) was used. The mobile phase consisted of
methanol:water:acetonitrile (3:6:2.5) with a flow rate of 1 mL/min
(Shimadzu Liquid Chromatography LC 10AS, Columbia, MD). The eluent was
monitored with an UV detector at 242 nm (Shimadzu UV-VIS Detector
SPD-10A), and chromatograms were analyzed using EZChrome software
(Shimadzu Scientific Instruments, Columbia, MD).  | Rheological Evaluation Steady shear Based on a preliminary screening, we found that formulations containing 1% and 2%
Avicel CL-611 had viscosity and yield stress similar to those of the commercial
formulation (Table 2). Hence, replicate batches were made only for creams containing 1% and 2% Avicel
CL-611. The thixotropic values for 1% or 2% Avicel CL-611 creams were lower than those
of the commercial formulation,indicating that these formulations had better structure
recovery properties. However, creams containing 4% and 6% Avicel CL-611 had much higher
thixotropic values, implying that these formulations took longer to rebuild viscosity at
rest after being sheared, which is potentially an undesirable property. A typical flow
curve (shear rate vs shear stress) of the cream containing 1% Avicel CL-611 is shown in Figure 1.
*Values in parentheses are standard deviations (n = 3).
?At selected points (6 sec-1, 12 sec-1, 100 sec-1).
?Bingham statistical model (σ = σy + Kγ, where σ = shear stress, σy = yield stress,
K = Bingham viscosity, γ = shear rate).
The yield stress values for the various formulations are reported in Table 2. The magnitude of yield stress relates to the strength of interparticle interaction in the three-dimensional network microstructure of the creams. Both 4% and 6% creams had higher yield stress values compared to the other three formulations, indicating more contact surfaces, stronger packing between particles, lower packing fraction (Φm), and less tendency for bridging flocculation. This is to be expected, since greater concentration of hydrocolloid will cause better interpenetration of the polymer coils. In contrast, the yield stress of the 1% Avicel CL-611 was the lowest, suggesting that a small stress is needed to initiate flow, which may be better in terms of applicability of the formulation to the skin. Although the stress values were the same for the cream containing 2% Avicel and the commercial formulation, the commercial cream took more time to rebuild its structure at rest after shear, as shown by the greater thixotropic value of the commercial cream. Henderson et al19 determined that creams generally encountered a shear rate of 120 sec-1 during topical application. Viscosity at this shear range could determine the ease of rubbing a cream or emulsion and hence influence the end-use performance of the product. Table 2 shows the viscosity of the various formulations used in this study at selected shear rates. The viscosities of the 1% and 2% formulations at shear rate of 100 sec-1 (1.58 and 1.9 Pa.s) were lower compared to the viscosity of commercial cream (2.4 Pa.s),
indicating better spreadability upon topical application of the formulations. Dynamic Mechanical Tests Strain sweep Creams prepared using 1% or 2% Avicel CL-611 had similar strain profiles (Figure 2A). The phase angle δ, which is a good indicator of the overall viscoelastic nature of the sample, was found to be 62° and 61° for the 1% and 2% Avicel, respectively, and 67° for the commercial cream (Figure 2D). These δ values range between 0° (ideal elastic solid) and 90° (completely viscous flow liquid), indicating that the creams are viscous enough to allow for spreading and rubbing on the skin. Looking at the values of tan δ for the commercial cream (2.36) compared to the 1% and 2% Avicel CL-611 formulations (1.80 and 1.88), commercial cream is more viscous. Tan δ greater than 3 indicates that particles are nonassociated; 1 < tan δ > 3 indicates that particles are weakly associated and tan δ < 1 signifies highly associated particles20. Therefore, it can be inferred that particles or the hydrocolloid polymer network within the laboratory-made cream products were more highly associated (more densely packed) or there was less bridging flocculation compared to the commercial cream21.
The elastic modulus, G’, for the 1% or 2% Avicel CL-611 and the commercial (Figures 2A and D) formulation was over G’’ with a good distance between them, signifying strong thickening or solidifying behavior. However, at about 10% strain, the products started to break down, with G’ and G’’ crossing each other. The lower strain is a desirable feature since it simulates the onset of spreading of cream on the skin, as discussed earlier under Steady shear. This would also allow better absorption from the skin, considering the fact that the cream has to spread well on the skin surface before absorption could take occur. In contrast, the 4% and 6% formulations did not show breakdown of elastic modulus (G’) and crossing with the loss modulus (G’’) until strain reached about 70% (Figures 2B and C). This demonstrates that greater strain is needed to cause effective spreading and rubbing, a correlation with the observed yield stress data discussed earlier under Steady shear above. The higher the percent strain, the stronger the cream structure. The greater strain is not desirable in a formulation, thus, 4% and 6% formulations were considered unsuitable. Therefore, knowledge of these viscoelastic indices could be used to predict the performance of topical delivery systems such as creams. Time sweep Creams prepared using 1% Avicel CL-611 had lower G’, G’’, and η’ compared to creams prepared using 2% Avicel CL-611 and commercial formulation (Table 3, Figures 3A and C). Interestingly, in creams containing 1% or 2% Avicel CL-611, the structure recovered rapidly, G’ (the solid-like component) never crossed G’’ (the liquid-like component) during the test. This indicates a strong network of polymer entanglement and possibly better long-term stability compared to the commercial product. The commercial formulation had an increase in G’ after preshearing that decreased substantially after approximately 600 seconds (Figure 3C, Table 3).
*Values in parentheses are standard deviations of the elastic modulus (G’).
NC = indicates no crossover of G’ with G’’, G’ > G’’
However, the formulations containing 4% or 6% Avicel CL-611 (Figure 3B) had much stronger solid-like properties (G’ was very predominant) compared to other formulations. This is in agreement with the high yield stress values needed to initiate flow and the longer time needed to rebuild structure at rest after shear, as reflected in the high thixotropic values in Table 2. The viscoelastic moduli, storage modulus (G’), and viscous modulus (G’’) are direct measurements of particle-particle interaction (i.e., they measure structural characteristics of the cream formulations). The response is sensitive to the amplitude of applied deformation, that is to strain or stress (γ or σ). Although the rheology is measured macroscopically, the measurement depends on microscopic considerations and it yields valuable information about the microstructure22. Drug Release The amount of the drug released (Q) was plotted against the square root of time (t), based on Fick?s law of diffusion.
In the above equation, A is the cross-sectional area of the Enhancer® Cell and C0 is the initial concentration of the drug in the formulation. The release of drug from the various creams fitted the square root of time relationship (Figure 4), indicating that the release was by diffusion. As expected, higher concentration of the Avicel CL-611 resulted in a slower drug release as a result of less bridging flocculation. This correlates with the relative viscosity data in Table 2, indicating that formulations with higher viscosity had lower release compared to the commercial formulation. The drug release profiles for creams containing 1% or 2% Avicel CL-611 were similar, while the release from the commercial formulation was faster than that of the other formulations. This could be due to the hydrophilic excipients such as ceteareth-20 (a surfactant) and sorbitol, a humectant that retards the recrystallization of dispersed solids, thus increasing the solubility of hydrocortisone acetate in the marketed product.

|
Microstructure characterization of the Avicel® CL-611 creams was investigated using rheological, dynamic mechanical viscoelastic measurements and drug release rate, and it revealed a dependence on the excipient level. Measurement of various rheological properties can serve as a good preformulation tool in predicting the performance of semisolids during processing, packaging, storage stability, spreadability during use, and subsequent absorption of the hydrocortisone. Such tests could also be considered for future regulatory guidance deliberations or USP specifications in addition to the current test for drug release. 
| We are grateful to John Colliopoulos and Dr. Bill Bubnis (formerly with FMC Corporation) for their technical assistance and suggestions. The project was supported financially through a grant awarded to M. C. A. by FMC Corporation, Princeton, NJ. We would like to thank Dr. Peter Whittingstall for his useful suggestions during the preparation of the manuscript. 
|
1.
Smith AK, Goff HD, Kakuda Y. Microstructure and rheological properties of whipped cream as affected by heat treatment and addition of stabilizer. Int Dairy J. 2000;10(4):295-301.
2.
Eccleston GM, Behan-Martin MK, Jones GR, Towns-Andrew E. Synchrotron X-ray investigations into lamellar gel phase formed in pharmaceutical creams prepared with cetrimide and fatty alcohols. Int J Pharm. 2000;203(1-2):127-139.
PubMed
3.
Dickinson E, Golding M. Influence of calcium ions on creaming and theology of emulsions containing sodium caseinate. Colloids Surf. A 1998;144: (1-3):167-177.
4.
Dickinson E, Golding M. Rheology of sodium caseinate stabilized oil-in-water emulsions. J Colloid Interface Sci. 1997;19(1):166-176.
PubMed
5.
Teo YH, Goddard P, Barrett DA, Melia CD. The microstructure of creams revealed by confocal laser scanning microscopy. J Pharm Pharmacol. 1998; 50(suppl):132.
6.
Regola A, Carnesi M, Dolfini A, Gazzaniga A. Use of thermogravimetry in the physicochemical characterization of hydrophilic creams. Boll Chim Farm. 1996; 135(2):67-71.
7.
Caldwell KB, Goff HD, Stanley D. A low-temperature scanning electron microscopy study of ice cream: II. Influence of selected ingredients and processes. Food Struct. 1992;11(1):11-23.
8.
Holland SJ, Warrack JK. Low-temperature scanning electron microscopy of the phase inversion process in a cream formulation. Int J Pharm. 1990;65(3):225-234.
9.
Niemi L, Laine E. Effect of water content on the microstructure of an o/w cream. Int J Pharm. 1991;68(1-3):205-214.
10.
Tiemessen HLGM, Van der Maarel JRC, Bodde HE, Jousma H, Jinginger HE. Probing the microstructure of liquid crystalline surfactant systems: a physicochemical study using the rheometry, DTA and oxygen-17 NMR. Neth J Controlled Release. 1990;13(1):73-81.
11.
Radebaugh, GW. Rheological and mechanical properties of dispersed Ssystems. In: Liberman HA,Rieger MM, and Banker GS, eds. Pharmaceutical Dosage Forms: Disperse Systems. 2nd ed. New York, NY: Marcel Dekker; 1996:153-209.
12.
Jones DS, Woolfson AD, Brown AF. Viscoelastic properties of bioadhesive, chlorhexidine-containing semisolids for topical application to the oropharynx. Pharm Res. 1998;15:1131-1136.
PubMed
13.
Tamburic S, Craig DQ, Vuleta G, Milic J. An investigation into the use of thermorheology and texture analysis in the evaluation of w/o creams stabilized with a silicone emulsifier. Pharm Dev Technol. 1996; 1:299-306. PubMed
14.
Yu DM, Amidon GL, Weiner ND, Goldberg AH. Viscoelastic properties of Poly(ethylene oxide) solution. J Pharm Sci. 1994; 83:1443-1449.
PubMed
15.
Gasperlin M, Tusar L, Tusar M, Kristl J, Smid-Korbar J. Lipophilic semisolid emulsion systems: viscoelastic behavior and prediction of physical stability by neural network. Int J Pharm. 1998; 168:243-254.
16.
Dolz M, Roldan C. The influence of heating time on the rheological behavior of a microcrystalline cellulose hydrogel. Pharmazie. 1992; 47:134-136.
17.
Avicel RC/CL Microcrystalline Cellulose and Carboxymethylcellulose Sodium, NF. Bulletin RC-16, FMC Corporation. 1988:3.
18.
Villivalam VD, Rege PR, Collins CC. Development in release testing of topical dosage forms: use of the Enhancer CellTM with automated sampling. J Pharm Biomed Anal. 1998; 17:1225-1233.
PubMed
19.
Henderson NL, Meer PM, Kostenbauder HB. Approximate rates of shear encountered in some pharmaceutical processes. J Pharm Sci. 1961; 50:788-791.
20.
Rohn CL. The rheology of coatings and dispersions. J. Water-borne Coatings. 1987:10(3):9, 12-17.
21.
Lippacher A, Muller RH, Mader K. Investigation on the viscoelastic properties of lipid -based colloidal drug carriers. Int J Pharm. 2000; 196:227-230. PubMed
22.
Ulbrich R. Rheology of liquids and viscoelastic characterization of semisolids, TA Instruments. Paper presented at: Duquesne University Pharmaceutical Seminar Series: Pharmaceutical Unit Processes and Liquid Dosage Form Development: Industry and Regulatory Perspectives: May 22-25, 2000; Pittsburgh, PA.

|
|